#24

How We Invest at Cota Capital

With Shubhra Jain, MD, Senior Associate of Cota Capital

Dr. Shubhra Jain joined Cota in 2018 as a Senior Associate where she is responsible for sourcing, executing and analyzing healthcare investments. Prior to Cota, Shubhra was Associate Director of Commercial Strategy and Corporate Development at Natera where she focused on Biopharma Partnerships, the diligence of potential acquisitions, market research and competitive positioning. Prior to Natera, she led Product management for Acute care suite of products at Pieces Technologies where she led product development and launch of SaaS risk surveillance and prediction solutions for clinical outcomes and published peer-reviewed research on the subject. Prior to Pieces, Dr. Jain served as a consultant and an advisor to several health tech startups and Fortune 500 companies.

Dr. Jain is a Primary Care Physician from India, has her Masters in Engineering from Stanford with a major in Biodesign and her MBA from the Wharton School of Business.

How We Invest at Cota Capital

US_UK_iTunes_Store_Get_Solid_Lockup_RGB_blk_012618.jpg

 

 

Shubhra Jain, MD, Senior Associate, Cota Capital

Shubhra.png

Dr. Shubhra Jain joined Cota in 2018 as a Senior Associate where she is responsible for sourcing, executing and analyzing healthcare investments. Prior to Cota, Shubhra was Associate Director of Commercial Strategy and Corporate Development at Natera where she focused on Biopharma Partnerships, the diligence of potential acquisitions, market research and competitive positioning. Prior to Natera, she led Product management for Acute care suite of products at Pieces Technologies where she led product development and launch of SaaS risk surveillance and prediction solutions for clinical outcomes and published peer-reviewed research on the subject. Prior to Pieces, Dr. Jain served as a consultant and an advisor to several health tech startups and Fortune 500 companies.

Dr. Jain is a Primary Care Physician from India, has her Masters in Engineering from Stanford with a major in Biodesign and her MBA from the Wharton School of Business.